Who We Are

New York Blood Center Enterprises

Leveraging the power of our divisions and business units, the mission of New York Blood Center Enterprises (NYBCe) has been amplified. NYBCe is one of the world’s largest independent community-based blood centers, serving over 75 million people across the country.

Learn more about each of our divisions and business units below.

Founded in 1964, New York Blood Center (NYBC) is a nonprofit organization that is one of the largest independent, community-based blood centers in the world. NYBC, along with its operating divisions Community Blood Center of Kansas City, Missouri (CBC), Innovative Blood Resources (IBR), Blood Bank of Delmarva (BBD), and Rhode Island Blood Center (RIBC), collect approximately 4,000 units of blood products each day and serve local communities of more than 75 million people in the Tri-State area (NY, NJ, CT), Mid Atlantic area (PA, DE, MD, VA), Missouri and Kansas, Minnesota, Nebraska, Rhode Island, and Southern New England. NYBC and its operating divisions also provide a wide array of transfusion-related medical services to over 500 hospitals nationally, including Comprehensive Cell Solutions, the National Center for Blood Group Genomics, the National Cord Blood Program, and the Lindsley F. Kimball Research Institute, which — among other milestones — developed a practical screening method for hepatitis B as well as a safe, effective and affordable vaccine, and a patented solvent detergent plasma process innovating blood-purification technology worldwide.

The Blood Bank of Delaware, as it was then known, was founded in 1954 as a non-profit, community-based blood center providing blood and blood products to hospitals and other organizations. In 1990, the organization merged with Blood Bank of the Eastern Shore to become Blood Bank of Delaware/Eastern Shore. In 2004 the organization changed its name to Blood Bank of Delmarva. Today, BBD serves 1.6 million people in New Castle, Kent and Sussex counties, Del.; Cecil County, Md.; Eastern Shore, Md. and Eastern Shore, Va. BBD is an FDA licensed member of America’s Blood Centers and accredited by AABB.

Community Blood Center (CBC), established over 40 years ago, serves hospitals in the Greater Kansas City metropolitan area, as well as eastern Kansas and western Missouri. CBC provides blood products to 70 area hospitals – and relies on volunteer donors each day to meet the need for life-saving gifts of blood. CBC provides high-quality reference immunohematology laboratory services, including platelet and red blood cell antibody testing, and therapeutic apheresis to local hospitals.

IBR Innovative Blood Resources Logo

Innovative Blood Resources is a non-profit community blood center that was formed in 2012 through the combination of two strong, nationally-recognized, community-based nonprofit blood centers: Minnesota-based Memorial Blood Centers, and Nebraska Community Blood Bank. With a combined 100 years of blood industry experience, IBR provides comprehensive product and service capabilities focusing on value-driven solutions for patients, hospitals, physicians, researchers, and other healthcare partners.

IBR is also home to IBR Biomedical Services, which grew from the nationally recognized research and clinical trial contributions of Memorial Blood Centers’ physicians and clinicians in blood banking and transfusion services. IBR Biomedical Services offers expertise in the areas of cellular therapy, clinical trial support, as well as regulatory and quality systems consulting.

MBC relies on the local community to donate blood to help ensure a safe and stable blood supply is available to area hospitals and other partners. With operations in Minnesota and Wisconsin, MBC is a Division of New York Blood Center, Inc. (a family of operating Divisions known as New York Blood Center Enterprises), serving communities across the country.


Nebraska Community Blood Bank (NCBB) has been connecting people and saving lives since 1968. NCBB relies on the local community to donate blood to help ensure a safe and stable blood supply is available to area hospitals and other partners. With operations in Nebraska and western Iowa, NCBB is a Division of New York Blood Center, Inc. (a family of operating Divisions known as New York Blood Center Enterprises), serving communities across the country.

Rhode Island Blood Center (RIBC) was founded in 1979 as a nonprofit community blood center. For over 35 years, RIBC has been the primary supplier of blood and blood products to patients being cared for in hospitals throughout Rhode Island and in neighboring states. Our mission is to help save lives by ensuring a safe, plentiful, and cost-effective blood supply. RIBC is also part of the National Marrow Donor Program and collects stem cells for transplant at its Providence location. RIBC provides therapeutic treatments for patients in local hospitals. Our state-of-the-art laboratory performs donor testing for over 400,000 donations per year. RIBC is also involved in a variety of local and national research programs in an effort to improve all aspects of the blood supply.

Connecticut Blood Center CTBC Logo

Established in 2021, the Connecticut Blood Center is a non-profit, community-based blood center operated by Rhode Island Blood Center. Located in Middletown, CT, CTBC provides blood products to patients being cared for in more than a dozen hospitals around Connecticut.

Comprehensive Cell Solutions builds on our excellence in science, research and development, medical services, laboratory services and blood. Today we offer a comprehensive menu of products and services to develop, improve, and implement scientific studies in the areas of regenerative medicine, cell therapies, transfusion medicine, and related scientific and medical endeavors. Our services provide access to our world-class clinical and scientific expertise.
Comprehensive Cell Solutions

Lindsley F. Kimball Research Institute (LFKRI) is the research branch of New York Blood Center. Since its establishment in 1964, LFKRI’s research efforts have paved the way for new blood-related products, techniques and therapies. The Institute’s commitment to ground-breaking research has resulted in numerous landmark patents and licenses. LFKRI’s areas of blood related research include transfusion medicine, hematology, infectious disease, epidemiology and cellular therapy.
Lindsley F. Kimball Research Institute

Built on a foundation of innovation and discovery and combining the scientific and research expertise of New York Blood Center and Community Blood Center of Kansas City, the National Center for Blood Group Genomics (NCBGG) specializes in applying precision medicine to blood transfusion to increase safety and minimize complications. Based in Kansas City, NCBGG’s mission is to provide the highest quality testing services for extended blood typing at lower cost for donor centers and the patients they serve to improve the practice of transfusion medicine, to develop the next generation of testing, and to train the next generation of leaders.

NYBC corporate publications reflect our commitment to standards, policies, and procedures that ensure we continue to achieve our mission and maintain our core values of quality, excellence, service, leadership, respect, innovation, compassion, integrity, maintaining public trust, and sharing knowledge.